RHDV K5

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

RABBIT HAEMORRHAGIC DISEASE VIRUS

Available from:

NSW DEPARTMENT OF PRIMARY INDUSTRIES

INN (International Name):

RHDV (calicivirus)

Pharmaceutical form:

WETTABLE POWDER

Composition:

RABBIT HAEMORRHAGIC DISEASE VIRUS BIOLOGICAL-VIRUS Active 0.0 LD50/mL

Units in package:

100mL

Class:

A - Agricultural

Therapeutic area:

VERTEBRATE POISON

Product summary:

Poison schedule: ; Withholding period: WHP: N/A; Host/pest details: PREPARATION OF BAITS: [EUROPEAN RABBIT]; RABBIT WARREN: [RABBIT]; Poison schedule: ; Withholding period: ; Host/pest details: PREPARATION OF BAITS: [EUROPEAN RABBIT]; RABBIT WARREN: [RABBIT]; For the infection of wild European rabbits in accordance with directions of the appropriate State or Territory government authority.See RESTRAINTS on label.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

Page 1 of 4
NSW DEPARTMENT OF PRIMARY
INDUSTRIES RHDV K5
80188/100372
COMPANY NAME:
PRODUCT NAME:
APVMA APPROVAL NO:
LABEL NAME:
RHDV K5
SIGNAL HEADINGS:
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
CONSTITUENT
STATEMENTS:
ACTIVE CONSTITUENT: RABBIT HAEMORRHAGIC DISEASE VIRUS, 08Q712 STRAIN
>30,000 ID50 UNITS
MODE OF ACTION:
STATEMENT OF
CLAIMS:
For the infection of wild European rabbits (Oryctolagus cuniculus) in
accordance with
directions of the appropriate State or Territory government authority.
NET CONTENTS:
At least 30,000 ID50 units of Lyophilised Rabbit Haemorrhagic Disease
Virus (RHDV)
08Q712 strain
RESTRAINTS:
DO NOT administer by injection to any animal other than wild European
rabbits.
DO NOT administer by injection to rabbits visibly affected by
myxomatosis. Rabbits
affected by active myxoma virus infection may be less likely to die as
a result of Rabbit
haemorrhagic disease (RHD).
DO NOT administer by injection to rabbits younger than 12 weeks.
Younger rabbits may be
infected with rabbit haemorrhagic disease virus (RHDV) but are less
likely to die as a result
of RHDV, particularly in the presence of maternal antibodies. RHDV may
be administered
to susceptible rabbits either by direct injection or by means of
infected carrot or oat feed.
DIRECTIONS FOR USE:
Administration by intramuscular injection:
Capture at least two wild rabbits from each warren. Using a sterile
syringe, reconstitute the
RHDV K5 lyophilised virus by adding 10 mL of sterile distilled water
and swirl gently for a
few minutes. Using a sterile syringe, remove a 0.5 mL dose of virus
suspension from the
vial. Inject each recipient rabbit at an intramuscular (IM) site in
the hind leg with 0.5 mL of
reconstituted virus suspension and release the rabbits back into the
warren from which they
were captured. RLP APPROVED
Page 2 of 4
It is recommended that rabbits be captured and re-released into the
same warren to
maximise the likelihood of acceptance of the infected rabbit by its
cohorts.
A minimum of two rab